Stay updated on ALADDIN Clinical Trial: dAroLutamide in Prostate Cancer
Sign up to get notified when there's something new on the ALADDIN Clinical Trial: dAroLutamide in Prostate Cancer page.

Latest updates to the ALADDIN Clinical Trial: dAroLutamide in Prostate Cancer page
- CheckyesterdayChange DetectedRecord History shows updates to Study Status on 2022-02-10 and Recruitment Status on 2024-03-11 for NCT05116475.SummaryDifference0.1%

- Check8 days agoNo Change Detected
- Check30 days agoChange Detected- Added a government funding lapse notice and operating-status guidance, and confirmed the NIH Clinical Center is open with sources. - Version updated from v3.1.0 to v3.2.0.SummaryDifference13%

- Check37 days agoChange DetectedUpdate to a newer software version label: from v3.0.2 to v3.1.0.SummaryDifference0.3%

- Check51 days agoChange DetectedRevision updated from v3.0.1 to v3.0.2. The 'Back to Top' link was removed, indicating a minor UI change.SummaryDifference0.8%

- Check59 days agoChange DetectedThe web page has been updated from version v3.0.0 to v3.0.1, indicating a revision in the content. There are no significant changes to core content, names, pricing, or availability.SummaryDifference0.8%

- Check66 days agoChange DetectedThe web page has undergone significant changes, including the addition of a facility name and location details, while several location-related terms have been removed.SummaryDifference6%

Stay in the know with updates to ALADDIN Clinical Trial: dAroLutamide in Prostate Cancer
Enter your email address, and we'll notify you when there's something new on the ALADDIN Clinical Trial: dAroLutamide in Prostate Cancer page.